Annovis Bio

About:

Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.

Website: http://annovisbio.com/

Twitter/X: qrpharma

Top Investors: BioAdvance, Ben Franklin Technology Partners of Southeastern Pennsylvania, BofA Securities, Keiretsu Forum, Delaware Crossing Investor Group

Description:

Annovis Bio is specialty pharmaceutical company founded to develop novel treatments for Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative disorders. The company has two compounds in clinical development: Posiphen® targets early stage AD and PD and may stop or slow the progression of the disease; BNC targets late stage AD and may stabilize the decline.